Pages that link to "Q44741839"
Jump to navigation
Jump to search
The following pages link to Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. (Q44741839):
Displaying 50 items.
- Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture (Q24631017) (← links)
- The E-screen assay: a comparison of different MCF7 cell stocks (Q28367480) (← links)
- ECC-1 human endometrial cells as a model system to study dioxin disruption of steroid hormone function (Q28372455) (← links)
- Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens (Q28485336) (← links)
- Direct, differential effects of tamoxifen, 4-hydroxytamoxifen, and raloxifene on cardiac myocyte contractility and calcium handling (Q28534675) (← links)
- The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells (Q28546094) (← links)
- In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control (Q28551368) (← links)
- Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development (Q28554883) (← links)
- Characterization of the isomeric configuration and impurities of (Z)-endoxifen by 2D NMR, high resolution LC⬜MS, and quantitative HPLC analysis (Q30668728) (← links)
- Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat (Q33257471) (← links)
- Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer (Q33611502) (← links)
- Transient administration of estradiol-17 beta establishes an autoregulatory loop permanently inducing estrogen receptor mRNA. (Q33650609) (← links)
- Synthesis and Evaluation of Estradiol Derivatives as Anti-Breast Cancer Agents. (Q33901785) (← links)
- Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors (Q34774040) (← links)
- Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy (Q35008045) (← links)
- Ligand-dependent differences in estrogen receptor beta-interacting proteins identified in lung adenocarcinoma cells corresponds to estrogenic responses. (Q35338975) (← links)
- Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants (Q35605724) (← links)
- Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer (Q35749331) (← links)
- Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol. (Q35991956) (← links)
- The effects of the administration of tamoxifen, ethynyloestradiol, and prednisolone on the activities of certain enzymes of carbohydrate metabolism in primary human breast carcinomas in vivo (Q35992282) (← links)
- Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines (Q36027345) (← links)
- Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression. (Q36030868) (← links)
- No effect on pharmacokinetics of tamoxifen and 4-hydroxytamoxifen by multiple doses of red clover capsule in rats (Q36245924) (← links)
- Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells (Q36619918) (← links)
- Design of a platinum-acridine-endoxifen conjugate targeted at hormone-dependent breast cancer (Q36712167) (← links)
- New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer (Q36927087) (← links)
- Mitogenic regulation of normal and malignant breast epithelium (Q36987868) (← links)
- Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites (Q37195375) (← links)
- Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen (Q37221922) (← links)
- Tamoxifen in the Mouse Brain: Implications for Fate-Mapping Studies Using the Tamoxifen-Inducible Cre-loxP System (Q37351902) (← links)
- A cell-biased effect of estrogen in prion infection. (Q37547427) (← links)
- Extraction of tamoxifen and its metabolites from formalin-fixed, paraffin-embedded tissues: an innovative quantitation method using liquid chromatography and tandem mass spectrometry (Q37597968) (← links)
- Cytogenetic and molecular biologic alterations in human breast cancer: a review (Q39826893) (← links)
- Estrogen mitogenic action. III. is phenol red a "red herring"? (Q40847961) (← links)
- 8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer (Q41366482) (← links)
- Effects of tamoxifen on human breast cancer cells in vitro (Q41585013) (← links)
- Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells (Q42221167) (← links)
- Oestrogen-induced pS2 protein is similar to pancreatic spasmolytic polypeptide and the kringle domain (Q42858625) (← links)
- Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. (Q43244977) (← links)
- Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites (Q43685275) (← links)
- Histone acetylation decreased by estradiol in the MCF-7 human mammary cancer cell line (Q45106547) (← links)
- Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells (Q50141897) (← links)
- Computer-aided design and synthesis of tetra-aryl-substituted alkenes and their bioevaluation as a selective modulator of estrogen-related receptor γ. (Q53480322) (← links)
- The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer. (Q54964664) (← links)
- Refined protocols of tamoxifen injection for inducible DNA recombination in mouse astroglia. (Q55118066) (← links)
- Inhibition of postconfluent focus production in cultures of MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (Q68061049) (← links)
- Immuno-biochemical assay for determination of nuclear steroid receptors during tamoxifen therapy (Q70711234) (← links)
- The influence of a novel cyclopropyl antiestrogen (compound 7a) on human breast cancer cells in culture (Q72919563) (← links)
- Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells (Q73503052) (← links)
- The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells (Q74502081) (← links)